-+ 0.00%
-+ 0.00%
-+ 0.00%

*MaxCyte To Acquire Akron Bio, Expanding Its Offerings Across Cell Therapy Manufacturing And Expecting To Nearly Double Revenue Base >MXCT

Dow Jones·11/10/2026 11:01:15

Veuillez vous connecter pour afficher les détails des actualités